🚨 www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis 🚨

Marcela Belleza, Kaue Malpighi e Caio Bastos conversam sobre manejo de hipercalcemia no PS.

Minutagem:
00:10 Apresentação
01:15 4 passos da Hipercalcemia
01:43 Classificação da Hipercalcemia
07:39 Manejo da Hipercalcemia
12:00 Terapia Medicamentosa
14:40 Denosumabe
24:46 Salves

Referências: 
1. Walker MD, Shane E. Hypercalcemia: A Review. JAMA. 2022;328(16):1624-1636. doi:10.1001/jama.2022.18331
2. LeGrand SB, Leskuski D, Zama I. Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med. 2008;149(4):259-263. doi:10.7326/0003-4819-149-4-200808190-00007
3. Hu MI, Glezerman IG, Leboulleux S, Insogna K, Gucalp R, Misiorowski W, Yu B, Zorsky P, Tosi D, Bessudo A, Jaccard A, Tonini G, Ying W, Braun A, Jain RK. Denosumab for treatment of hypercalcemia of malignancy. J Clin Endocrinol Metab. 2014 Sep;99(9):3144-52. doi: 10.1210/jc.2014-1001. Epub 2014 Jun 10. PMID: 24915117; PMCID: PMC4154084.
4. Guise TA, Wysolmerski JJ. Cancer-Associated Hypercalcemia [published correction appears in N Engl J Med. 2022 Jul 7;387(1):96. doi: 10.1056/NEJMx220006]. N Engl J Med. 2022;386(15):1443-1451. doi:10.1056/NEJMcp2113128
5. El-Hajj Fuleihan G, Clines GA, Hu MI, et al. Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2023;108(3):507-528. doi:10.1210/clinem/dgac621